10-K Filing

TRANSMEDICS GROUP, INC. CIK: 1756262 FY 2019

Filing Information

Form Type	10-K
Accession Number	`0001564590-20-011409`
Period End Date	20191231
Filing Date	20200317
Fiscal Year	2019
Fiscal Period	FY
XBRL Instance	tmdx-20191228.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 69 Income Statement 75 Cash Flow Statement 67 Stockholders Equity 30 Comprehensive Income 20

Balance Sheet 69 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$20.09M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$20.24M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$60.60M	USD	Point-in-time
Accounts receivable, net of $0 allowance	`AccountsReceivableNetCurrent`	$3.44M	USD	Point-in-time
Accounts receivable, net of $0 allowance	`AccountsReceivableNetCurrent`	$6.56M	USD	Point-in-time
Inventory	`InventoryNet`	$9.28M	USD	Point-in-time
Inventory	`InventoryNet`	$11.22M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.84M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.54M	USD	Point-in-time
Accounts Receivable, Allowance	`AllowanceForDoubtfulAccountsReceivable`	-	USD	Point-in-time
Total current assets	`AssetsCurrent`	$34.79M	USD	Point-in-time
Accounts Receivable, Allowance	`AllowanceForDoubtfulAccountsReceivable`	-	USD	Point-in-time
Total current assets	`AssetsCurrent`	$100.00M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$3.47M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$4.79M	USD	Point-in-time
Deferred offering costs	`DeferredOfferingCostsNoncurrent`	$3.38M	USD	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$500.00K	USD	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$500.00K	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$6.00K	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$6.00K	USD	Point-in-time
Total assets	`Assets`	$42.16M	USD	Point-in-time
Total assets	`Assets`	$105.30M	USD	Point-in-time
Temporary Equity, Shares Authorized	`TemporaryEquitySharesAuthorized`	50.78M	shares	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$7.25M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$4.72M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesAndOtherLiabilities`	$8.33M	USD	Point-in-time
Temporary Equity, Shares Outstanding	`TemporaryEquitySharesOutstanding`	50.40M	shares	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesAndOtherLiabilities`	$7.18M	USD	Point-in-time
Preferred Stock, No Par Value	`PreferredStockNoParValue`	-	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$166.00K	USD	Point-in-time
Preferred Stock, No Par Value	`PreferredStockNoParValue`	-	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$306.00K	USD	Point-in-time
Preferred Stock, No Par Value	`PreferredStockNoParValue`	-	USD	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	25.00M	shares	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	25.00M	shares	Point-in-time
Current portion of deferred rent	`DeferredRentCreditCurrent`	$370.00K	USD	Point-in-time
Current portion of deferred rent	`DeferredRentCreditCurrent`	$349.00K	USD	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	0.00	shares	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$12.55M	USD	Point-in-time
Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$16.11M	USD	Point-in-time
Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock warrant liability	`PreferredStockWarrantsAndRightsOutstanding`	$898.00K	USD	Point-in-time
Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Long-term debt, net of discount and current portion	`LongTermDebtNoncurrent`	$33.67M	USD	Point-in-time
Long-term debt, net of discount and current portion	`LongTermDebtNoncurrent`	$34.15M	USD	Point-in-time
Deferred rent, net of current portion	`DeferredRentCreditNoncurrent`	$759.00K	USD	Point-in-time
Deferred rent, net of current portion	`DeferredRentCreditNoncurrent`	$389.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$47.88M	USD	Point-in-time
Total liabilities	`Liabilities`	$50.65M	USD	Point-in-time
Commitments and contingencies (Note 13)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 13)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Convertible preferred stock (Series A-1, B, B-1, C, D, E and F) $0.0001 par value; no shares and 50,776,054 shares authorized at December 28, 2019 and December 29, 2018, respectively; and no shares and 50,404,140 shares issued and outstanding at December 28, 2019 and December 29, 2018, respectively	`TemporaryEquityCarryingAmountAttributableToParent`	$186.52M	USD	Point-in-time
Preferred stock, no par value; 25,000,000 shares and no shares authorized at December 28, 2019 and December 29, 2018, respectively; no shares issued and outstanding at December 28, 2019 and December 29, 2018	`PreferredStockValueNoParValue`	-	USD	Point-in-time
Preferred stock, no par value; 25,000,000 shares and no shares authorized at December 28, 2019 and December 29, 2018, respectively; no shares issued and outstanding at December 28, 2019 and December 29, 2018	`PreferredStockValueNoParValue`	-	USD	Point-in-time
Common stock, no par value; 150,000,000 shares and no shares authorized at December 28, 2019 and December 29, 2018, respectively; 21,184,524 shares and no shares issued and outstanding at December 28, 2019 and December 29, 2018, respectively	`CommonStockValueNoParValue`	-	USD	Point-in-time
Common stock, no par value; 150,000,000 shares and no shares authorized at December 28, 2019 and December 29, 2018, respectively; 21,184,524 shares and no shares issued and outstanding at December 28, 2019 and December 29, 2018, respectively	`CommonStockValueNoParValue`	$424.13M	USD	Point-in-time
Common stock, $0.0001 par value; no shares and 60,000,000 shares authorized at December 28, 2019 and December 29, 2018, respectively; no shares issued and 1,397,800 shares issued at December 28, 2019 and December 29, 2018, respectively; and no shares and 1,397,493 shares outstanding at December 28, 2019 and December 29, 2018, respectively	`CommonStockValue`	$1.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$143.79M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-101.00K	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-2.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-335.94M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-369.48M	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquity`	$-192.24M	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquity`	$54.65M	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquity`	$-168.72M	USD	Point-in-time
Total liabilities, convertible preferred stock and stockholders equity (deficit)	`LiabilitiesAndStockholdersEquity`	$105.30M	USD	Point-in-time
Total liabilities, convertible preferred stock and stockholders equity (deficit)	`LiabilitiesAndStockholdersEquity`	$42.16M	USD	Point-in-time

Income Statement 75 line items

Line Item	Tag	Value	Unit	Period
Net revenue	`Revenues`	$2.92M	USD	1 Quarter
Net revenue	`Revenues`	$6.06M	USD	1 Quarter
Net revenue	`Revenues`	$4.04M	USD	1 Quarter
Net revenue	`Revenues`	$7.21M	USD	1 Quarter
Net revenue	`Revenues`	$5.67M	USD	1 Quarter
Net revenue	`Revenues`	$13.02M	USD	Annual
Net revenue	`Revenues`	$4.68M	USD	1 Quarter
Net revenue	`Revenues`	$23.60M	USD	Annual
Net revenue	`Revenues`	$2.52M	USD	1 Quarter
Net revenue	`Revenues`	$3.54M	USD	1 Quarter
Cost of revenue	`CostOfRevenue`	$7.28M	USD	Annual
Cost of revenue	`CostOfRevenue`	$9.74M	USD	Annual
Gross profit	`GrossProfit`	$2.57M	USD	1 Quarter
Gross profit	`GrossProfit`	$924.00K	USD	1 Quarter
Gross profit	`GrossProfit`	$3.33M	USD	1 Quarter
Gross profit	`GrossProfit`	$4.22M	USD	1 Quarter
Gross profit	`GrossProfit`	$5.73M	USD	Annual
Gross profit	`GrossProfit`	$13.86M	USD	Annual
Gross profit	`GrossProfit`	$1.50M	USD	1 Quarter
Gross profit	`GrossProfit`	$3.74M	USD	1 Quarter
Gross profit	`GrossProfit`	$2.13M	USD	1 Quarter
Gross profit	`GrossProfit`	$1.18M	USD	1 Quarter
Research, development and clinical trials	`ResearchAndDevelopmentExpense`	$13.66M	USD	Annual
Research, development and clinical trials	`ResearchAndDevelopmentExpense`	$19.87M	USD	Annual
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$12.31M	USD	Annual
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$23.60M	USD	Annual
Total operating expenses	`OperatingExpenses`	$25.97M	USD	Annual
Total operating expenses	`OperatingExpenses`	$43.47M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-8.69M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-3.94M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-6.36M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-7.71M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-29.60M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-4.78M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-5.96M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-20.24M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-5.16M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-7.24M	USD	1 Quarter
Interest expense	`InterestExpense`	$4.35M	USD	Annual
Interest expense	`InterestExpense`	$2.72M	USD	Annual
Change in fair value of preferred stock warrant liability	`FairValueAdjustmentOfWarrants`	$545.00K	USD	Annual
Change in fair value of preferred stock warrant liability	`FairValueAdjustmentOfWarrants`	$341.00K	USD	Annual
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$790.00K	USD	Annual
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$-213.00K	USD	Annual
Total other expense, net	`NonoperatingIncomeExpense`	$-3.90M	USD	Annual
Total other expense, net	`NonoperatingIncomeExpense`	$-3.48M	USD	Annual
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-33.51M	USD	Annual
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-23.71M	USD	Annual
Provision for income taxes	`CurrentIncomeTaxExpenseBenefit`	$41.00K	USD	Annual
Provision for income taxes	`CurrentIncomeTaxExpenseBenefit`	$40.00K	USD	Annual
Net loss	`NetIncomeLoss`	$-4.90M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-23.76M	USD	Annual
Net loss	`NetIncomeLoss`	$-8.28M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.89M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.11M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-33.55M	USD	Annual
Net loss	`NetIncomeLoss`	$-9.20M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-7.63M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.12M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-9.18M	USD	1 Quarter
Net loss per share attributable to common stockholders, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-3.73	USD	1 Quarter
Net loss per share attributable to common stockholders, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-8.24	USD	2 Qtrs
Net loss per share attributable to common stockholders, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.43	USD	1 Quarter
Net loss per share attributable to common stockholders, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-5.48	USD	1 Quarter
Net loss per share attributable to common stockholders, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-4.57	USD	1 Quarter
Net loss per share attributable to common stockholders, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.39	USD	1 Quarter
Net loss per share attributable to common stockholders, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-2.36	USD	Annual
Net loss per share attributable to common stockholders, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-17.48	USD	Annual
Net loss per share attributable to common stockholders, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-4.86	USD	1 Quarter
Net loss per share attributable to common stockholders, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-3.61	USD	1 Quarter
Net loss per share attributable to common stockholders, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.70	USD	1 Quarter
Weighted average common shares outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	1.34M	shares	2 Qtrs
Weighted average common shares outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	1.36M	shares	Annual
Weighted average common shares outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	1.34M	shares	1 Quarter
Weighted average common shares outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	14.20M	shares	Annual

Cash Flow Statement 67 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-23.76M	USD	Annual
Net loss	`ProfitLoss`	$-33.55M	USD	Annual
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$769.00K	USD	Annual
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$1.22M	USD	Annual
Stock-based compensation expense	`ShareBasedCompensation`	$144.00K	USD	Annual
Stock-based compensation expense	`ShareBasedCompensation`	$854.00K	USD	Annual
Change in fair value of preferred stock warrant liability	`FairValueAdjustmentOfWarrants`	$545.00K	USD	Annual
Change in fair value of preferred stock warrant liability	`FairValueAdjustmentOfWarrants`	$341.00K	USD	Annual
Non-cash interest and end of term accretion expense	`NonCashInterestAndEndOfTermAccretionExpense`	$177.00K	USD	Annual
Non-cash interest and end of term accretion expense	`NonCashInterestAndEndOfTermAccretionExpense`	$475.00K	USD	Annual
Net amortization (accretion) of premiums (discounts) on marketable securities	`AmortizationOfDebtDiscountPremium`	$-205.00K	USD	Annual
Net amortization (accretion) of premiums (discounts) on marketable securities	`AmortizationOfDebtDiscountPremium`	$9.00K	USD	Annual
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-305.00K	USD	Annual
Unrealized foreign currency transaction losses	`ForeignCurrencyTransactionGainLossUnrealized`	$-150.00K	USD	Annual
Unrealized foreign currency transaction losses	`ForeignCurrencyTransactionGainLossUnrealized`	$-200.00K	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$3.17M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$2.51M	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	$2.70M	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	$4.12M	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$1.35M	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-250.00K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$164.00K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$3.44M	USD	Annual
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$2.45M	USD	Annual
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$2.34M	USD	Annual
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-136.00K	USD	Annual
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$67.00K	USD	Annual
Deferred rent	`IncreaseDecreaseInDeferredCharges`	$329.00K	USD	Annual
Deferred rent	`IncreaseDecreaseInDeferredCharges`	$349.00K	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-25.98M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-32.29M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$165.00K	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$418.00K	USD	Annual
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$82.37M	USD	Annual
Proceeds from sales and maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$12.72M	USD	Annual
Proceeds from sales and maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$22.04M	USD	Annual
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$12.31M	USD	Annual
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-60.50M	USD	Annual
Proceeds from issuance of long-term debt, net of issuance costs	`ProceedsFromIssuanceOfLongTermDebt`	$33.44M	USD	Annual
Repayments of long-term debt	`RepaymentsOfLongTermDebt`	$9.08M	USD	Annual
Proceeds from issuance of common stock in initial public offering, net of underwriting discounts and commissions	`ProceedsFromIssuanceOfCommonStockInInitialPublicOfferingNetOfUnderwritingDiscountsAndCommissions`	$97.37M	USD	Annual
Payments of initial public offering and other financing costs	`PaymentOfFinancingAndStockIssuanceCosts`	$4.85M	USD	Annual
Payments of initial public offering and other financing costs	`PaymentOfFinancingAndStockIssuanceCosts`	$2.34M	USD	Annual
Proceeds from issuance of common stock upon exercise of stock options	`ProceedsFromStockOptionsExercised`	$202.00K	USD	Annual
Proceeds from issuance of common stock upon exercise of stock options	`ProceedsFromStockOptionsExercised`	$46.00K	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$92.72M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$22.06M	USD	Annual
Effect of exchange rate changes on cash, cash equivalents and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-85.00K	USD	Annual
Effect of exchange rate changes on cash, cash equivalents and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-82.00K	USD	Annual
Net (decrease) increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-149.00K	USD	Annual
Net (decrease) increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$8.30M	USD	Annual
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$20.59M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$12.44M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$20.74M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$20.59M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$12.44M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$20.74M	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	$2.40M	USD	Annual
Cash paid for interest	`InterestPaidNet`	$3.88M	USD	Annual
Conversion of convertible preferred stock to common stock upon initial public offering	`ConversionOfConvertiblePreferredStockToCommonStockUponInitialPublicOffering`	$186.52M	USD	Annual
Transfers of inventory to property and equipment	`InventoryTransferToPropertyPlantAndEquipment`	$1.39M	USD	Annual
Transfers of inventory to property and equipment	`InventoryTransferToPropertyPlantAndEquipment`	$2.15M	USD	Annual
Reclassification of warrant liability to equity upon initial public offering	`ReclassificationOfWarrantLiabilityToEquityUponInitialPublicOffering`	$1.24M	USD	Annual
Purchases of property and equipment included in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$169.00K	USD	Annual
Offering costs included in accounts payable and accrued expenses	`OfferingCostsIncludedInAccountsPayableAndAccruedExpenses`	$1.04M	USD	Annual
Offering costs included in accounts payable and accrued expenses	`OfferingCostsIncludedInAccountsPayableAndAccruedExpenses`	$120.00K	USD	Annual
Settlement of accrued financing fee	`SettlementOfAccruedFinancingFee`	$124.00K	USD	Annual

Stockholders Equity 30 line items

Line Item	Tag	Value	Unit	Period
Discounts and issuance costs of stock issued	`AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts`	$5.97M	USD	Annual
Balance	`StockholdersEquity`	$-192.24M	USD	Point-in-time
Balance	`StockholdersEquity`	$54.65M	USD	Point-in-time
Balance	`StockholdersEquity`	$-168.72M	USD	Point-in-time
Conversion of convertible preferred stock into common stock upon initial public offering	`StockIssuedDuringPeriodValueConversionOfUnits`	$186.52M	USD	Annual
Conversion of preferred stock warrants into common stock warrants upon initial public offering	`ConversionOfPreferredStockWarrantsIntoCommonStockWarrantsUponInitialPublicOffering`	$1.24M	USD	Annual
Issuance of common stock in initial public offering,net of discounts and issuance costs of $5,966	`StockIssuedDuringPeriodValueNewIssues`	$91.40M	USD	Annual
Issuance of common stock upon the exercise of common stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$46.00K	USD	Annual
Issuance of common stock upon the exercise of common stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$202.00K	USD	Annual
Issuance of common stock upon the exercise of common stock options, Shares	`StockIssuedDuringPeriodSharesStockOptionsExercised`	124,226.00	shares	Annual
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$854.00K	USD	Annual
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$144.00K	USD	Annual
Settlement of accrued financing fees	`StockIssuedDuringPeriodValueSettlementOfAccruedFinancingFee`	$124.00K	USD	Annual
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$41.00K	USD	Annual
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$45.00K	USD	Annual
Unrealized gains (losses) on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$54.00K	USD	Annual
Unrealized gains (losses) on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$7.00K	USD	Annual
Net loss	`NetIncomeLoss`	$-4.90M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-23.76M	USD	Annual
Net loss	`NetIncomeLoss`	$-8.28M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.89M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.11M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-33.55M	USD	Annual
Net loss	`NetIncomeLoss`	$-9.20M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-7.63M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.12M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-9.18M	USD	1 Quarter
Balance	`StockholdersEquity`	$-192.24M	USD	Point-in-time
Balance	`StockholdersEquity`	$54.65M	USD	Point-in-time
Balance	`StockholdersEquity`	$-168.72M	USD	Point-in-time

Comprehensive Income 20 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-4.90M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-23.76M	USD	Annual
Net loss	`NetIncomeLoss`	$-8.28M	USD	1 Quarter
Other Comprehensive Income (Loss), Securities, Available-for-Sale, Unrealized Holding Gain (Loss) Arising During Period, Tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	-	USD	Annual
Net loss	`NetIncomeLoss`	$-6.89M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.11M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-33.55M	USD	Annual
Net loss	`NetIncomeLoss`	$-9.20M	USD	1 Quarter
Other Comprehensive Income (Loss), Securities, Available-for-Sale, Unrealized Holding Gain (Loss) Arising During Period, Tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	-	USD	Annual
Net loss	`NetIncomeLoss`	$-7.63M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.12M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-9.18M	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$41.00K	USD	Annual
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$45.00K	USD	Annual
Unrealized gains (losses) on marketable securities, net of tax of $0	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$54.00K	USD	Annual
Unrealized gains (losses) on marketable securities, net of tax of $0	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$7.00K	USD	Annual
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$99.00K	USD	Annual
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$48.00K	USD	Annual
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-23.71M	USD	Annual
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-33.45M	USD	Annual

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.